USP Methods for Microbial Contamination in Supplements, CBD Hemp and Probiotics

In this presentation, USP and Eurofins Microbiology provide an overview of USP microbiology methods tests for microbial contamination in dietary supplements, CBD/hemp products, and probiotics. The session includes an in-depth discussion regarding the importance of suitability testing, and a comparison of USP methodology to AOAC/FDA BAM methodology. USP will also provide an update on new USP chapters and share insight on what is on the horizon for USP methods. Speakers: USP - Kit Goldman – Director, Dietary Supplements and Herbal Medicines Eurofins Microbiology– Shannon Jacoby-Business Unit Manager and David Roth-Senior Client Services Manager This webinar originally aired on Wednesday, November 18, 2020. CHAPTERS: 00:00 Introduction 05:12 The Value of Public Standards 07:24 USP Documentary Standards-Compendial Hierarchy 12:07 Compendial Microbiology Tests 28:52 Additional Points on 60 33:30 USP Applicable Products 45:15 What is New at USP? 50:31 Q&A